Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Sori, Tukaram
- A Rare Case Report of Risperidone Induced Steven Johnson Syndrome
Abstract Views :623 |
PDF Views:302
Authors
Affiliations
1 Department of Psychiatry, SDM College of Medical Sciences and Hospital, Dharwad,Karnataka, IN
2 Department of Dermatology, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, IN
3 Department of Psychiatry, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, IN
1 Department of Psychiatry, SDM College of Medical Sciences and Hospital, Dharwad,Karnataka, IN
2 Department of Dermatology, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, IN
3 Department of Psychiatry, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, IN
Source
Indian Journal of Drugs and Diseases, Vol 1, No 7 (2012), Pagination: 171-172Abstract
Stevens-Johnson syndrome (SJS) is the most severe cutaneous adverse reactions to medications. It is characterized by the detachment of dead epidermis and the erosions of mucous membranes. Either drugs or infectious agents may cause SJS. But risperidone induced SJS is not so for reported and first time we are reporting this case. The woman developed SJS when she was started on risperidone for her HIV induced psychosis. Her appearance and recovery of SJS symptoms were rapid and there was apparent correlation between initiation and recovery of symptoms with risperidone.Keywords
Risperidone, Steven Johnson Syndrome, Drug ReactionReferences
- Becker DS (1998) Toxic epidermal necrolysis. Lancet. 35, 1417- 1420.
- Prendiville J (2002) Stevens-Johnson syndrome and toxic epidermal necrolysis. Adv. Dermatol. 18,151-73.
- Pereira FA, Mudgil AV and Rosmarin DM (2007) Toxic epidermal necrolysis. J. Am. Acad. Dermatol.56, 181-200
- Desarkar P and Nizamie SH (2006) Risperidone-induced erythema multiforme minor. Br. J. Clin. Pharmacol. 62, 4 504-505
- Gerardin AP, Abadie FV and Campestrini JA (1976) Pharmacokinetics of carbamazepine in normal humans after single and repeated oral doses. J. Pharmacokinet. Biopharm.4(6), 521-535
- Temesgen Z and Beri G (2004) HIV and drug allergy. Immunol. Allergy Clin. North Am. 24,521-531.